These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 18834226)
1. CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels. Lee S; Cho NY; Yoo EJ; Kim JH; Kang GH Arch Pathol Lab Med; 2008 Oct; 132(10):1657-65. PubMed ID: 18834226 [TBL] [Abstract][Full Text] [Related]
2. Association between molecular subtypes of colorectal cancer and patient survival. Phipps AI; Limburg PJ; Baron JA; Burnett-Hartman AN; Weisenberger DJ; Laird PW; Sinicrope FA; Rosty C; Buchanan DD; Potter JD; Newcomb PA Gastroenterology; 2015 Jan; 148(1):77-87.e2. PubMed ID: 25280443 [TBL] [Abstract][Full Text] [Related]
3. Characterization of Chilean patients with sporadic colorectal cancer according to the three main carcinogenic pathways: Microsatellite instability, CpG island methylator phenotype and Chromosomal instability. Wielandt AM; Hurtado C; Moreno C M; Villarroel C; Castro M; Estay M; Simian D; Martinez M; Vial MT; Kronberg U; López-Köstner F Tumour Biol; 2020 Jul; 42(7):1010428320938492. PubMed ID: 32635826 [TBL] [Abstract][Full Text] [Related]
4. Unique characteristics of CpG island methylator phenotype (CIMP) in a Chinese population with colorectal cancer. Liu J; Tang L; Yi J; Li G; Lu Y; Xu Y; Zhao S; Mao R; Li X; Ren L; Wang K BMC Gastroenterol; 2019 Nov; 19(1):173. PubMed ID: 31690257 [TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy. Murcia O; Juárez M; Rodríguez-Soler M; Hernández-Illán E; Giner-Calabuig M; Alustiza M; Egoavil C; Castillejo A; Alenda C; Barberá V; Mangas-Sanjuan C; Yuste A; Bujanda L; Clofent J; Andreu M; Castells A; Llor X; Zapater P; Jover R PLoS One; 2018; 13(9):e0203051. PubMed ID: 30188916 [TBL] [Abstract][Full Text] [Related]
6. Association between risk factors, molecular features and CpG island methylator phenotype colorectal cancer among different age groups in a Taiwanese cohort. Chen KH; Lin LI; Yuan CT; Tseng LH; Chao YL; Liang YH; Liang JT; Lin BR; Cheng AL; Yeh KH Br J Cancer; 2021 Jul; 125(1):48-54. PubMed ID: 33846524 [TBL] [Abstract][Full Text] [Related]
7. Cimp-Positive Status is More Representative in Multiple Colorectal Cancers than in Unique Primary Colorectal Cancers. Tapial S; Olmedillas-López S; Rueda D; Arriba M; García JL; Vivas A; Pérez J; Pena-Couso L; Olivera R; Rodríguez Y; García-Arranz M; García-Olmo D; González-Sarmiento R; Urioste M; Goel A; Perea J Sci Rep; 2019 Jul; 9(1):10516. PubMed ID: 31324877 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology and Molecular-Pathologic Characteristics of CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer. Advani SM; Swartz MD; Loree J; Davis JS; Sarsashek AM; Lam M; Lee MS; Bressler J; Lopez DS; Daniel CR; Morris V; Shureqi I; Kee B; Dasari A; Vilar E; Overman M; Hamilton S; Maru D; Braithwaite D; Kopetz S Clin Colorectal Cancer; 2021 Jun; 20(2):137-147.e1. PubMed ID: 33229221 [TBL] [Abstract][Full Text] [Related]
9. Multiregional assessment of CIMP in primary colorectal cancers: Phenotype concordance but marker variability. Flatin BTB; Vedeld HM; Pinto R; Langerud J; Lind GE; Lothe RA; Sveen A; Jeanmougin M Int J Cancer; 2021 Apr; 148(7):1652-1657. PubMed ID: 33284993 [TBL] [Abstract][Full Text] [Related]
10. SMO expression in colorectal cancer: associations with clinical, pathological, and molecular features. Li T; Liao X; Lochhead P; Morikawa T; Yamauchi M; Nishihara R; Inamura K; Kim SA; Mima K; Sukawa Y; Kuchiba A; Imamura Y; Baba Y; Shima K; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S; Qian ZR Ann Surg Oncol; 2014 Dec; 21(13):4164-73. PubMed ID: 25023548 [TBL] [Abstract][Full Text] [Related]
11. Specific mutations in KRAS codons 12 and 13, and patient prognosis in 1075 BRAF wild-type colorectal cancers. Imamura Y; Morikawa T; Liao X; Lochhead P; Kuchiba A; Yamauchi M; Qian ZR; Nishihara R; Meyerhardt JA; Haigis KM; Fuchs CS; Ogino S Clin Cancer Res; 2012 Sep; 18(17):4753-63. PubMed ID: 22753589 [TBL] [Abstract][Full Text] [Related]
12. Association Between Molecular Subtypes of Colorectal Tumors and Patient Survival, Based on Pooled Analysis of 7 International Studies. Phipps AI; Alwers E; Harrison T; Banbury B; Brenner H; Campbell PT; Chang-Claude J; Buchanan D; Chan AT; Farris AB; Figueiredo JC; Gallinger S; Giles GG; Jenkins M; Milne RL; Newcomb PA; Slattery ML; Song M; Ogino S; Zaidi SH; Hoffmeister M; Peters U Gastroenterology; 2020 Jun; 158(8):2158-2168.e4. PubMed ID: 32088204 [TBL] [Abstract][Full Text] [Related]
13. Aberrant DNA methylation patterns in microsatellite stable human colorectal cancers define a new marker panel for the CpG island methylator phenotype. Gebhard C; Mulet-Lazaro R; Glatz D; Schwarzfischer-Pfeilschifter L; Schirmacher P; Gaedcke J; Weichert W; Reuschel E; Dietmaier W; Rehli M Int J Cancer; 2022 Feb; 150(4):617-625. PubMed ID: 34591983 [TBL] [Abstract][Full Text] [Related]
14. Enrichment of Bacteroides fragilis and enterotoxigenic Bacteroides fragilis in CpG island methylator phenotype-high colorectal carcinoma. Takashima Y; Kawamura H; Okadome K; Ugai S; Haruki K; Arima K; Mima K; Akimoto N; Nowak JA; Giannakis M; Garrett WS; Sears CL; Song M; Ugai T; Ogino S Clin Microbiol Infect; 2024 May; 30(5):630-636. PubMed ID: 38266708 [TBL] [Abstract][Full Text] [Related]
15. A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification. Nishihara R; Morikawa T; Kuchiba A; Lochhead P; Yamauchi M; Liao X; Imamura Y; Nosho K; Shima K; Kawachi I; Qian ZR; Fuchs CS; Chan AT; Giovannucci E; Ogino S Am J Epidemiol; 2013 Jul; 178(1):84-100. PubMed ID: 23788674 [TBL] [Abstract][Full Text] [Related]
16. Association Between Smoking and Molecular Subtypes of Colorectal Cancer. Wang X; Amitay E; Harrison TA; Banbury BL; Berndt SI; Brenner H; Buchanan DD; Campbell PT; Cao Y; Chan AT; Chang-Claude J; Gallinger SJ; Giannakis M; Giles GG; Gunter MJ; Hopper JL; Jenkins MA; Lin Y; Moreno V; Nishihara R; Newcomb PA; Ogino S; Phipps AI; Sakoda LC; Schoen RE; Slattery ML; Song M; Sun W; Thibodeau SN; Toland AE; Van Guelpen B; Woods MO; Hsu L; Hoffmeister M; Peters U JNCI Cancer Spectr; 2021 Aug; 5(4):. PubMed ID: 34377935 [TBL] [Abstract][Full Text] [Related]
17. Deciphering the etiology and role in oncogenic transformation of the CpG island methylator phenotype: a pan-cancer analysis. Yates J; Boeva V Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35134107 [TBL] [Abstract][Full Text] [Related]
18. Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history. Weisenberger DJ; Levine AJ; Long TI; Buchanan DD; Walters R; Clendenning M; Rosty C; Joshi AD; Stern MC; LeMarchand L; Lindor NM; Daftary D; Gallinger S; Selander T; Bapat B; Newcomb PA; Campbell PT; Casey G; Ahnen DJ; Baron JA; Haile RW; Hopper JL; Young JP; Laird PW; Siegmund KD; Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):512-519. PubMed ID: 25587051 [TBL] [Abstract][Full Text] [Related]
19. The CpG Island Methylator Phenotype Status in Synchronous and Solitary Primary Colorectal Cancers: Prognosis and Effective Therapeutic Drug Prediction. Weng YY; Huang MY Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791280 [TBL] [Abstract][Full Text] [Related]
20. Somatic alterations, metabolizing genes and smoking in rectal cancer. Curtin K; Samowitz WS; Wolff RK; Herrick J; Caan BJ; Slattery ML Int J Cancer; 2009 Jul; 125(1):158-64. PubMed ID: 19358278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]